

Molecular and genetic features of iris and choroidal melanoma
https://doi.org/10.25557/2073-7998.2025.07.119-122
Abstract
Purpose: Analysis of the frequency of molecular genetic aberrations in tumour tissue and blood in patients with iris melanoma.
Methods. 140 patients with uveal melanoma (UM) were analysed by methyl-sensitive PCR. The experimental group included 48 patients with iris melanoma (group A) and 62 patients with spread to the ciliary body (group B). Group C (comparison) consisted of 30 patients with melanoma in 2012.
Results. The spindle cell tumour type was significantly more frequent in subgroup 1p+8p (A) compared to subgroup M3+1p (A) (p=0.049), and the mixed cell type was more frequent in subgroup M3+1p (A) compared to subgroup 1p+8p (A) (p=0.049). In the subgroup of complete M3 (C), tumour spread to the ciliary body was significantly more often determined compared to other subgroups (p=0.035). In the partial M3 (C) subgroup, there was a significant association of the frequency of partial monosomy of chromosome 3 with mixed-cell and epithelioid-cell type UM (p=0.014 and 0.042, respectively). In iris melanoma, deletion of the entire short arm of chromosome 1 was found in 68.7%, chromosome 8 in 47.9%, with spread to the ciliary body in 77.4% and 51.6%, respectively, and in chorioideal melanoma in 30% and 20% of cases. No mutations in the GNAQ/GNA11 genes were detected in group A. In group B, one heterozygous mutation in GNAQ/GNA11 genes was detected in 2 patients. In group C, mutations in GNAQ/GNA11 genes were detected in 27 patients (90%). When comparing the frequency of heterozygous mutation in GNAQ/ GNA11 genes, significant differences were obtained between the experienced groups and the comparison group (F=0.0000001, χ2 =56.45). The CC genotype of the C3435T polymorphic marker of the ABCB1 gene was found in 90% (F= 0.026418, χ2 =5.36, significantly more frequent compared with group III) in group I, in 92.3% (F= 0.006183, χ2 =7.75 significantly more frequent compared with group III) in group II, and in 60% in group III. TT genotype was not detected in any group.
Conclusion. The identified features confirm the more favourable nature of the tumour process in iris melanomas compared to choroidal melanomas.
About the Authors
A. Iu. TsygankovRussian Federation
14/19, Sadovaya–Chernogryazskaya st., Moscow, 105062;
4, Dolgorukovskaya st., Moscow, 127006
S. V. Saakyan
Russian Federation
14/19, Sadovaya–Chernogryazskaya st., Moscow, 105062;
4, Dolgorukovskaya st., Moscow, 127006
I. V. Svirina
Russian Federation
14/19, Sadovaya–Chernogryazskaya st., Moscow, 105062
A. M. Burdennyi
Russian Federation
8, Baltiyskaya st., Moscow, 125315
V. I. Loginov
Russian Federation
8, Baltiyskaya st., Moscow, 125315
References
1. Grishina E.E., Lerner M.Yu., Gemdzhyan E.G. Epidemiologiya uveal’noy melanomy v g. Moskve [Epidemiology of uveal melanomas in Moscow]. Al’manakh klinicheskoy meditsiny [Almanac of Clinical Medicine]. 2017; 45(4):321–5. (In Russ.) DOI: 10.18786/2072-0505-2017-45-4-321-325
2. Popovic M., Ahmed I.I.K.., Di Giovanni J., Shields C.L. Radiotherapeutic and surgical management of iris melanoma: A review. Surv Ophthalmol. 2017; 62(3):302-311. DOI: 10.1016/j.survophthal.2016.12.012
3. Jager M.J., Shields C.L., Cebulla C.M., et al. Uveal melanoma. Nature Reviews Disease Primers 2020; 6(1):24. DOI: 10.1038/ s41572-020-0158-0
4. Kaliki S., Shields C.L. Uveal melanoma: relatively rare but deadly cancer. Eye (Lond). 2017; 31(2):241-257. DOI: 10.1038/eye.2016.275
5. Singh M., Durairaj P., Yeung J. Uveal Melanoma: A review of the literature. Oncol. Ther. 2018; 6(1):87–104. DOI: 10.1007/s40487-018-0056-8
6. Jamison A., Bhatti L.A., Sobti M.M., et.al. Uveal melanoma-associated survival in Scotland. Eye (London) 2019; 33:1699–1706. DOI: 10.1038/s41433-019-0622-9
Review
For citations:
Tsygankov A.I., Saakyan S.V., Svirina I.V., Burdennyi A.M., Loginov V.I. Molecular and genetic features of iris and choroidal melanoma. Medical Genetics. 2025;24(7):119-122. (In Russ.) https://doi.org/10.25557/2073-7998.2025.07.119-122